SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

DWTX highlights Halneuron potential for chemotherapy-induced neuropathic pain

Halneuron, a selective NaV1.7 inhibitor, is positioned as a first-in-class, durable therapy for chemotherapy-induced neuropathic pain, citing durable efficacy and a strong safety profile in clinical trials.

DWTX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories